Skip To Main Content
Raymond Berglund on Muck Rack

Raymond Berglund

As seen in: Mondaq
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Raymond Berglund’s profile

Articles by Raymond Berglund

Proactive Measures: How PE CFOs Can Steer Clear Of Debt Covenant Breaches In A Shifting Market

|
By Raymond Berglund, Ed Manning, Tim Metzgen, Jessika Van Veen
| Mondaq
The Private Equity (PE) community is vibrant these days, especially the CFOs who are steering their firms through challenging times. The current market landscape is nothing short of volatile, with economic uncertainties looming large and the ever-present risk of breaching debt covenants — an indication of underlying distress and underperformance. In this article, we explore various operational strategies that can help PE CFOs navigate these challenges effectively.
Open in Who Shared Issue with article?

Harnessing The Three C's: Cash, Cost And COGS - A Strategic Blueprint For CFOs - Financial Services - UK

|
By Raymond Berglund, Christina Barakett
| Mondaq
In a rapidly evolving business landscape, Chief Financial Officers (CFOs) must not only keep a vigilant eye on the present but also anticipate the future. The key to enduring success lies in the mastery of three fundamental elements: Cash, Cost and Cost of Goods Sold (COGS). Alvarez & Marsal's CFO Services team works closely with clients to help them navigate economic uncertainty by focusing on the "three C's" that serve as critical levers to improve performance and secure a competitive edge.
Open in Who Shared Issue with article?

Applying Agile Software Development Concepts To Pharmaceutical Manufacturing And Distribution Footprint Optimisation

|
By Jean Laurent Poitou, Lee Feander, John Morgan, Raymond Berglund
| Mondaq
How pharmaceutical companies can take learnings from high-growth technology businesses to continuously optimise their footprint and pay down footprint design debt. Continued aftereffects of the COVID-19 pandemic, Russia's invasion of Ukraine and surging inflation are the latest triggers for pharmaceutical companies to rethink how they manufacture and distribute products to their customers.
Open in Who Shared Issue with article?
Show More